Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TMEM184C pseudogene 1 (TMEM184CP1) is a human pseudogene corresponding to the TMEM184C gene (Transmembrane protein 184C). Unlike its parent gene, which is predicted to encode a transmembrane transporter with possible cell growth and tumor suppressor roles, TMEM184CP1 does not encode a functional protein. Pseudogenes like TMEM184CP1 are generally regarded as genetic remnants and not as pharmaceutical or biological targets. There is currently no evidence for a specific biological function, disease relevance, or therapeutic potential for TMEM184CP1. TMEM184CP1 is a nonfunctional pseudogene, not a therapeutic target, with no known biological, clinical, or pharmacological relevance. If your intent is to target or study a functional protein, refer instead to the parent gene, TMEM184C.
None, not applicable (no drugs target this pseudogene)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TMEM184C pseudogene 1 (TMEM184CP1).